Editorial: Discovery, development and implementation of improved options for treating opioid overdose in the synthetic opioid era

• Christian Heidbreder,
• Mark K. Greenwald,
• Bernard Le Foll,
• Phil Skolnick

Affiliations

Christian Heidbreder

Research & Development, Indivior, Inc., Chesterfield, VA, United States

Mark K. Greenwald

Department of Psychiatry and Behavioral Neurosciences, School of Medicine, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI, United States

Bernard Le Foll

Translational Addiction Research Laboratory, Centre for Addiction and Mental Health, Toronto, ON, Canada

Phil Skolnick

Research & Development, Indivior, Inc., Chesterfield, VA, United States